The vast majority of NSCLC cases are either adenocarcinoma or squamous ... prescribe if you have ROS1-positive lung cancer. This is known as off-label drug use. Off-label drug use means a drug ...

AstraZeneca AZN announced that the FDA expanded the label ... from lung cancer, the drug is also approved in the country for biliary tract cancer, endometrial cancer and hepatocellular carcinoma ...

Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

EGFR inhibitors are efficacious as second-line or third-line treatment for advanced non-small-cell lung cancer (NSCLC ... smokers from East Asia with lung adenocarcinoma. In this open-label ...